HM89 Regimen - CISMeF

Preferred Label : HM89 Regimen;

NCIt synonyms : SFOP-HM89 Regimen; COP-COPADM-VEM-VAD Regimen; HM89;

NCIt definition : A regimen administered in four phases that is used for the treatment of disseminated, childhood, anaplastic large cell lymphoma (ALCL). The 4 phases in the regimen include: COP (cyclophosphamide, vincristine and prednisone); COPADM (cyclophosphamide, vincristine, prednisone, doxorubicin, and methotrexate); VEM (etoposide, cyclophosphamide and methotrexate); and VAD (vincristine and doxorubicin).;

NCIt note : Source: PDQ;

Détails

Origin ID

C67212;

UMLS CUI

C1881025;

Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Cyclophosphamide [NCIt concept]
- Doxorubicin [NCIt concept]
- Etoposide [NCIt concept]
- Methotrexate [NCIt concept]
- Prednisone [NCIt concept]
- Vincristine [NCIt concept]
concept_is_in_subset
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]
regimen_has_accepted_use_for_disease
- Childhood Anaplastic Large Cell Lymphoma [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients